Recently Released Market Study: Switzerland Pharmaceuticals & Healthcare Report Q3 2012
BMI View: The period 2011-16 is forecast to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines market, which will increasingly attract prominent international players in the field, as well as prompt local companies to get more involved in the segment. According to data published by Swissmedic, Sandoz Pharmaceuticals, Novartis's generic medicines arm, has 556 preparations locally approved, while Teva has 345 preparations locally approved. However, the implementation of further price controls on the already low-value...
View full press release